The nicotine giant, Altria Group (MO), has been making headlines in the market lately. Analysts are closely watching its movements as it navigates a complex landscape. Key factors driving Altria's stock price include its reliance on traditional cigarettes, the rise of vaping and alternative nicotine options, and evolving laws. Furthermore, Altria's

Semaglutide can be a powerful tool for managing weight and diabetes in women, but like all medications, it comes with potential side effects. While many women experience minimal or manageable side effects, some may encounter more noticeable ones. It's essential for women to be cognizant of these possible side effects and share them with their healt